SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2.79 |
Enterprise Value ($M) | -0.58 |
Book Value ($M) | 0.61 |
Book Value / Share | 0.46 |
Price / Book | 4.60 |
NCAV ($M) | -0.75 |
NCAV / Share | -0.57 |
Price / NCAV | -3.71 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -35.02 |
Return on Assets (ROA) | -1.02 |
Return on Equity (ROE) | -2.22 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.91 |
Current Ratio | 0.91 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 7.44 |
Assets | 8.80 |
Liabilities | 8.20 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.42 |
Operating Income | -25.45 |
Net Income | -22.55 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -16.11 |
Cash from Investing | -0.01 |
Cash from Financing | 0.85 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Dellora Investments LP | 0.00 | -100.00 | |
13G/A | Schonfeld Strategic Advisors LLC | 0.18 | -99.75 | |
13G/A | Altium Capital Management LP | 4.99 | -53.70 | |
13G/A | Acorn Bioventures, L.p. | 0.00 | -100.00 | |
13G | Lind Global Fund II LP | 9.90 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1) | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,252,163 | 17,283,617 | 30.39 | |
4,554,885 | 14,810,229 | 30.75 | |
42,293 | 143,694 | 29.43 | |
43,040 | 36,387 | 118.28 | |
(click for more detail) |
Similar Companies | |
---|---|
CTXR – Citius Pharmaceuticals, Inc. | CUE – Cue Biopharma, Inc. |
CVKD – Cadrenal Therapeutics, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
CYRX – Cryoport, Inc. |